Distinct learning-progression job: Build reasoning from the question “how does a large polar peptidoglycan precursor cross a hydrophobic bacterial membrane before becoming cell wall?” to Lipid II synthesis, MurJ recognition, inward-facing binding, central-cavity electrostatics, alternating access, outward release, membrane-potential/ion effects, carrier recycling and the handoff to extracellular peptidoglycan polymerases.
Canonical boundary: MreB and the Bacterial Elongasome remains the owner of lateral wall growth. Peptidoglycan Recycling remains the owner of muropeptide salvage. Bacterial Undecaprenyl Phosphate Carrier Recycling owns C55-carrier reuse. This article owns MurJ-mediated Lipid II flipping from the cytoplasmic to the external leaflet of the inner membrane before polymerization.
Reader-safety boundary: General bacterial cell biology only. No antimicrobial-design or inhibition protocol is provided.
Wait, What? The Cell Wall Is Built Outside, but Its Main Precursor Is Made Inside
Lipid II contains a hydrophobic undecaprenyl tail, a charged pyrophosphate, a disaccharide and a peptide stem. The tail belongs in membrane; the headgroup strongly prefers water.
cytoplasmic precursor synthesis → Lipid II → MurJ flipping → external-leaflet delivery → glycan polymerization and peptide crosslinking
The One-Sentence Answer
Learn MurJ as an alternating-access Lipid II transporter: the undecaprenyl tail remains membrane associated while the charged headgroup enters a polar, cationic central cavity in inward-facing MurJ; substrate binding and transporter gating move through occluded toward outward-facing states; Lipid II is released to the periplasmic leaflet where SEDS proteins and PBPs incorporate it into peptidoglycan; and MurJ resets for another cycle, with membrane potential and homolog-specific ion effects modulating transport.
Learning Ladder
Beginner: MurJ flips a cell-wall building block from one side of the bacterial membrane to the other.
Secondary / Pre-University: membranes, hydrophobic/hydrophilic molecules, transport proteins and bacterial walls.
Undergraduate: Lipid I, Lipid II, undecaprenyl carrier, MurJ, inward/outward states, alternating access, peptidoglycan and RodA/FtsW.
Advanced / Professional: substrate-binding intermediates, charged-residue networks, lateral membrane grooves, ion coupling, in-vivo crosslinking, precursor accumulation and carrier-cycle closure.
Stage Progression
1. Begin with peptidoglycan
It is a glycan mesh crosslinked by peptides outside the cytoplasmic membrane.
2. Early precursors are cytoplasmic
UDP-linked sugar–peptide intermediates are assembled before membrane anchoring.
3. Undecaprenyl phosphate becomes the carrier
The long lipid tail anchors the precursor in the membrane.
4. Lipid I forms first
MurNAc-pentapeptide is transferred to the carrier.
5. Lipid II adds GlcNAc
The mature disaccharide-pentapeptide precursor is formed.
6. Lipid II is strongly amphipathic
Simple spontaneous flip-flop is energetically disfavoured.
7. MurJ is the major flippase in many bacteria
Genetic, biochemical and structural evidence support this assignment.
8. MurJ belongs to the MOP superfamily
Its architecture is related to other oligosaccharidyl-lipid transporters.
9. MurJ has fourteen transmembrane helices
The first twelve form two lobes around a central cavity.
10. TMs 13–14 contribute a hydrophobic groove
This can accommodate the lipid tail while the polar head enters the cavity.
11. The cavity contains essential positive residues
Conserved arginines help recognize the pyrophosphate-rich headgroup.
12. Inward-facing MurJ opens to the cytoplasmic leaflet
Newly synthesized Lipid II can enter.
13. The tail remains membrane associated
MurJ need not move the entire amphipathic molecule through an aqueous pore.
14. The headgroup is shielded from lipid
This is the central energetic service of the flippase.
15. Binding is not transport
Some mutants bind Lipid II yet fail to complete conformational cycling.
16. MurJ uses alternating access
The cavity is exposed to one membrane side at a time.
17. Occluded states isolate the substrate
They prevent an uncontrolled transmembrane pore.
18. Outward-facing MurJ exposes Lipid II externally
The headgroup can then enter the periplasmic leaflet.
19. Release is not polymerization
MurJ delivers the precursor; it does not build the wall polymer.
20. RodA/FtsW and PBPs act downstream
SEDS glycosyltransferases and transpeptidases consume flipped Lipid II.
21. Both elongasome and divisome depend on the same precursor supply
MurJ supports sidewall and septal synthesis.
22. Membrane potential influences cycling
In E. coli, depolarization shifts MurJ conformation and impairs transport.
23. Ion dependence differs among homologues
Thermosipho MurJ shows chloride-linked behaviour not identically shared by E. coli MurJ.
24. One structure is not every species
Transport coupling must be measured in the relevant homologue.
25. MurJ must reset
After release it returns toward an inward-facing state.
26. The lipid carrier also must be recycled
Undecaprenyl pyrophosphate generated after polymerization must be converted and returned for reuse.
27. Blocking MurJ causes inner-leaflet precursor accumulation
Lipid II is made but cannot reach downstream synthases.
28. Cell shape and lysis are downstream phenotypes
They do not uniquely identify MurJ because many wall enzymes produce similar outcomes.
29. Direct transport evidence is stronger than morphology
Precursor chemistry and conformational measurements are essential.
30. Professional closure test
Ask whether Lipid II was synthesized normally, whether it bound MurJ, whether MurJ traversed inward, occluded and outward states, whether the precursor reached the external leaflet, whether downstream synthases consumed it and whether carrier recycling restored another cycle.
Evidence: What Proves What?
Substrate relationship: conditional depletion, Lipid II accumulation, photo-crosslinking and substrate-binding mutants.
Alternating access: inward/outward structures, cysteine accessibility and conformational crosslinking.
Energetics: membrane-potential perturbation, ion-dependence assays and homolog comparisons.
Wall output: peptidoglycan incorporation, muropeptide analysis and shape recovery.
Connections Worth Making
Elongasome/Divisome: MurJ supplies the precursor that wall synthases consume.
Carrier Recycling: precursor delivery depends on continued C55-phosphate reuse.
Membrane Biophysics: MurJ shields a charged headgroup during transbilayer movement.
Misconceptions Worth Hunting
- “Peptidoglycan is synthesized entirely in the cytoplasm.” Polymerization occurs outside.
- “Lipid II is soluble.” It is lipid anchored.
- “MurJ polymerizes peptidoglycan.” It flips precursor.
- “Alternating access opens both sides together.” It avoids that state.
- “Binding proves transport.” Cycling can fail after binding.
- “RodA and MurJ do the same job.” One polymerizes, one flips.
- “All MurJ proteins use identical ions.” Homologues differ.
- “A shape defect proves MurJ failure.” Many wall pathways affect shape.
Transfer Check
Lipid II synthesis is normal but MurJ is inactive. Where should precursor accumulate? The cytoplasmic leaflet.
A MurJ mutant binds Lipid II but cannot become outward facing. Is recognition sufficient? No.
MurJ works but RodA/PBP2 fails. Can Lipid II reach the outer leaflet yet fail sidewall polymerization? Yes.
Membrane potential collapses while MurJ abundance is unchanged. Can transport still fail? Yes.
How We Know the Learning Has Held
A learner should be able to trace Lipid I to Lipid II; explain the amphipathic transport problem; describe MurJ’s cavity and groove; explain alternating access; distinguish binding from transport; connect membrane potential and homolog-specific ions; and distinguish MurJ from downstream synthases and carrier recycling.
Model Limits
MurJ homologues differ across bacteria. Structures from E. coli, Thermosipho and Staphylococcus do not define one universal ion-coupling scheme. In-vivo Lipid II pools are small and rapidly consumed. Membrane-potential perturbations have many cellular effects, so causal controls are needed.
Professional MurJ reasoning keeps Lipid II synthesis + substrate binding + transporter conformation + energetic coupling + external-leaflet delivery + downstream polymerization + carrier reuse visible together.
Teaching Guide
peptidoglycan → undecaprenyl carrier → Lipid I → Lipid II → amphipathic problem → MurJ architecture → inward binding → occlusion → outward release → membrane potential/ions → RodA/FtsW/PBPs → carrier recycling → evidence/model limits.
Connect This to the eduKate Learning Estate
Research Foundations and Further Learning
- Genetic and biochemical establishment of MurJ as a Lipid II flippase.
- 2017 inward-facing MurJ structure.
- 2019 multi-state structures defining alternating access.
- In-vivo conformational crosslinking and membrane-potential studies.
- Substrate-capture work separating Lipid II binding from transport progression.
- Recent comparisons of diderm and monoderm MurJ homologues.
The Quiet Ending
The beginner asks: “How does a cell-wall building block get outside the membrane?”
The developing microbiologist asks: “How does MurJ protect the charged part of Lipid II?”
The advanced learner asks: “Did this mutant fail to bind the substrate or fail to change conformation?”
Can we close one peptidoglycan-precursor flux from cytoplasmic Lipid II synthesis through MurJ cycling to external-leaflet delivery and productive wall polymerization strongly enough to distinguish failed flipping from failed downstream assembly?
